According to Eagle Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is โน22.42 Billion. In 2022 the company made a revenue of โน26.19 Billion an increase over the revenue in the year 2021 that were of โน12.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | โน21.13 B | -19.32% |
2022 | โน26.19 B | 105.19% |
2021 | โน12.76 B | -7.04% |
2020 | โน13.73 B | -1.68% |
2019 | โน13.96 B | -6.34% |
2018 | โน14.91 B | -1.31% |
2017 | โน15.11 B | 17.38% |
2016 | โน12.87 B | 192.56% |
2015 | โน4.40 B | 261.54% |
2014 | โน1.21 B | 11.4% |
2013 | โน1.09 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | โน7.778 T | 34,584.78% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | โน3.534 T | 15,658.66% | ๐ฌ๐ง UK |
![]() Novartis NVS | โน4.634 T | 20,564.65% | ๐จ๐ญ Switzerland |
![]() Teva Pharmaceutical Industries TEVA | โน1.446 T | 6,351.15% | ๐ฎ๐ฑ Israel |
![]() Amgen AMGN | โน2.971 T | 13,150.19% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | โน4.267 T | 18,926.60% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | โน4.148 T | 18,395.75% | ๐บ๐ธ USA |